Literature DB >> 8823387

Production of tumor necrosis factor in spinal cord following traumatic injury in rats.

C X Wang1, B Nuttin, H Heremans, R Dom, J Gybels.   

Abstract

Production of tumor necrosis factor (TNF) in the spinal cord following traumatic injury has been studied. In these experiments, the level of TNF was examined in the homogenate of the spinal cord, cerebrospinal fluid (CSF) and serum (n = 56). TNF could be detected in the injured spinal cord but not in the normal spinal cord. The TNF level increased in the spinal cord after the injury. At the lesion site, a maximal TNF concentration was observed 1 h after the injury, and the TNF concentration remained at this level until 8 h after the injury. Thereafter, it decreased gradually. However, TNF still could be detected 72 h after the injury. No TNF could be detected in the CSF and serum, collected from rats both with and without spinal cord injury (SCI). This study thus suggests that TNF is produced locally in the spinal cord following traumatic injury, and this TNF production is caused by the injury. The present results also demonstrate that TNF production is an acute and rapid reaction in the spinal cord following traumatic injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823387     DOI: 10.1016/0165-5728(96)00080-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  43 in total

Review 1.  AMPA-receptor trafficking and injury-induced cell death.

Authors:  Michael S Beattie; Adam R Ferguson; Jacqueline C Bresnahan
Journal:  Eur J Neurosci       Date:  2010-07-14       Impact factor: 3.386

2.  Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord.

Authors:  Kristina A Kigerl; John C Gensel; Daniel P Ankeny; Jessica K Alexander; Dustin J Donnelly; Phillip G Popovich
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

3.  Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.

Authors:  W K Kim; Y Kan; D Ganea; R P Hart; I Gozes; G M Jonakait
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

4.  Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury.

Authors:  A G Yakovlev; S M Knoblach; L Fan; G B Fox; R Goodnight; A I Faden
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

5.  Upregulation of tumor necrosis factor alpha transport across the blood-brain barrier after acute compressive spinal cord injury.

Authors:  W Pan; A J Kastin; R L Bell; R D Olson
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

6.  Anti-alpha4beta1 integrin antibody induces receptor internalization and does not impair the function of circulating neutrophilic leukocytes.

Authors:  Jennifer C Fleming; Feng Bao; Gediminas Cepinskas; Lynne C Weaver
Journal:  Inflamm Res       Date:  2010-03-07       Impact factor: 4.575

7.  Glucocorticoid receptor expression in the spinal cord after traumatic injury in adult rats.

Authors:  P Yan; J Xu; Q Li; S Chen; G M Kim; C Y Hsu; X M Xu
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

Review 8.  Cytokine transport across the injured blood-spinal cord barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 9.  Plasticity in respiratory motor neurons in response to reduced synaptic inputs: A form of homeostatic plasticity in respiratory control?

Authors:  K M Braegelmann; K A Streeter; D P Fields; T L Baker
Journal:  Exp Neurol       Date:  2016-07-22       Impact factor: 5.330

10.  Anti-inflammatory and antiapoptotic effect of interleukine-18 binding protein on the spinal cord ischemia-reperfusion injury.

Authors:  Ergün Karavelioğlu; Yücel Gönül; Serdar Kokulu; Ömer Hazman; Fatih Bozkurt; Ahmet Koçak; Olcay Eser
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.